INTERNATIONAL PATENT: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED FILES APPLICATION FOR "P2X3 ANTAGONIST FORMULATION"

GENEVA, Feb. 2 -- GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED (GSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY) filed a patent application (PCT/EP2025/071400) for "P2X3 ANTAGONIST FORMULATION" on Jul 24, 2025. With publication no. WO/2026/022326, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CHAURET, Nathalie (c/o GSKGSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY), GARCEAU, Denis (c/o GSKGSK Medicines Research CentreGunnels Wood RoadStevenage SG1 2NY), OJITO BETANCOURT, Aimesthe...